AUDACIOUS Reports Fiscal Q3 2022 Financial Results


Ryan Allway

March 1st, 2022

News, Top News


Continued Execution

2,400% YoY Revenue Growth

49% Growth in Gross Margins Over Q2

Reduced Losses, Positioned for further Growth

Earnings Conference Call Wednesday 2 March 2022 at 11am EST

 

LAS VEGASMarch 1, 2022 /PRNewswire/ – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA”, “AUDACIOUS”, or the “Company”), today announced that the Company has filed its financials and management discussion and analysis for the three-month period ending December 31, 2021, its fiscal third quarter of fiscal 2022 (the year ending March 31, 2022). The Company’s results are filed on www.sedar.com.

 

Australis Capital Inc. logo (CNW Group/Australis Capital Inc.)
Australis Capital Inc. logo (CNW Group/Australis Capital Inc.)

Terry Booth, CEO of AUDACIOUS, commented, “The third quarter saw us expand internationally through our partnership with Green Triangle Health (“GTH”), where we have already started generating revenues. Our partner is exceptionally well-connected, which is translating into commercial arrangements with major regional and international distributors. In the U.S., we continue to make good headway too, with an important partnership with First Americans of the Saint Regis Mohawk Tribe, which sees us move into New York well ahead of statewide commencement of adult use sales, providing us with a significant early mover advantage. Our partnership with PBR has seen us launch our Wreck Relief brand, which is now starting to generate online sales, and our Provisions and LOOS brands continue to do very well in California, in part through our partnership with EAZE, the world’s largest legal cannabis delivery company.”

 

Jon Paul, CFO of AUDACIOUS, added, “The third quarter was an important pivot for us, as we spent heavily towards future growth opportunities while moving further from our past. We successfully launched the AUDACIOUS brand at our highly trafficked booth at MJBizCon and the Roll-Up Launch Event featuring Machine Gun Kelly. We had our first sales in California while also investing heavily in key raw materials to expand our capacity for future quarters. We began funding our relationship with PBR and built inventory in Wreck Relief for the Q4 release. Even with loss of revenue from past fintech and consulting lines, we still grew sales over Q2 and have multiple opportunities for even faster sales growth in the quarters ahead.”

 

Financial Highlights Q3 Fiscal 2022

Income
Statement
3 months
ended
3 months
ended
Change

Year Over
Year

3 months
ended
Change

Q3 Over
Q2

Pro Forma
31-Dec-21 31-Dec-20 30-Sept-21 31-Dec-21
$ $ % $ % $
Revenue 2,371,218 90,378 2,623% 2,271,830 4.4% 2,940,876
Gross profit (loss) 1,843,437 (166,048) n.a. 1,233,766 49.4%
Operating expenses 6,164,519 4,898,793 25.8% 5,637,907 9.3%
Loss from operations (4,321,082) (5,064,841) -14.7% (4,404,141) -1.9%

 

Outlook

In the months ahead, AUDACIOUS will continue to execute on its strategy with further growth in its current markets and anticipates entering new jurisdictions, including New YorkNew Jersey, and others, as well as further expansion of its product line portfolio. Additionally, the Company will be pursuing multiple initiatives to increase production volume, further driving growth. The Company is following rigorous financial discipline and anticipates reducing certain operating expenses in the coming months. Additionally, following conversations with the regulators in Nevada, the Company is confident the license transfers relating to the GT acquisition will be completed shortly, following which the Company can consolidate the GT results, further boosting growth.

 

3Q 2022 Financial Highlights

  • Total revenues of $2.37 million, an increase of 2,623% year-over-year from $90,378 in the third fiscal quarter of 2021 and even grew 4% compared to the second quarter of fiscal quarter of 2022. During the quarter under review, the Company recorded its first billings in California, offset by lower kiosk income as the Cocoon business is wound down. Furthermore, as the Company had commenced exiting its investment in Body and Mind, no further consulting fees were generated from this relationship.
  • Gross profit for the fiscal second quarter of 2022 was $1.84 million compared to a gross profit loss of ($166k) in the comparable period of 2021 and increased by 51% from the second fiscal quarter of 2022. The increase in gross profit is predominantly from stronger utilization rates in the Company’s high-margin ALPS business and management fees from Green Therapeutics.
  • Operating expenses increased to approximately $6.16 million, or by 25.8%, as compared to the same period in the prior year, well below the recorded revenue growth rate of over 2,400% for the same period, showing the leverage built into the business as commercial activity increases. Cost increases driving this revenue growth were increases in personnel with the acquisition of ALPS and key management, the Company’s successful rebranding as Audacious launched at MJBizCon, annual governance meeting costs, and investment in the relationship with the Professional Bull Riders (PBR) association.
  • A 16% reduction in operating loss was recorded $(4.3) million as compared to $(5.1) million for the prior year, with growth in margins offsetting increased operating costs.

 

Q3 Highlights and Subsequent Events

  • LDA Funding – securing growth capital
  • MJBizCon
  • Excellent start to global activities – GTH partnership in Thailand
  • Bringing APIS to a new and significant audience – Priva partnership
  • Speeding up high-quality cultivation – The AUDACIOUS ACHIEVE series
  • From the desert to the arctic – ALPS develops profitable facilities anywhere – Pure Harvest $1.4M Kuwait deal
  • Making waves in California – Herbs + EAZE
  • PBR partnership off to successful start
  • License applications
  • Award streak continues

 

 

Conference Call Details

The Company will be hosting a conference call to discuss its results for the quarter on Wednesday, March 2, 2022, at 11am ET.

 

Conference call details

Canada: 1.647.794.4605
North American Toll Free: 1.888.204.4368
Webcast URL: https://produceredition.webcasts.com/starthere.jsp?ei=1532386&tp_key=0ca289c8c0
Confirmation #: 5701328
 

 

A replay of the call will be available until March 9, 2022. The replay can be accessed as follows:

Encore Replay Canada: 1.647.436.0148
Encore Replay North American Toll Free: 1.888.203.1112
Encore Replay Entry Code: 5701328

 

About AUDACIOUS

AUDACIOUS is a next-generation MSO growing the cannabis industry of tomorrow from the ground up, led by industry pioneer Terry Booth and an accomplished management team with proven industry track records. With operations that range from providing industry-leading sustainable cultivation design and optimization to retail storefronts, growing flower in-house, and manufacturing award-winning brands, AUDACIOUS has products and solutions for everyone. Quickly expanding through innovative partnerships and collaborations, AUDACIOUS is forging the inclusive cannabis community of tomorrow, today. Learn more about AUDACIOUS here.

 

AUDACIOUS common shares trade on the CSE under the symbol “AUSA” and on the OTCQB under the symbol “AUSAF.”

Terry Booth

 

________________________________

Terry Booth
Chief Executive Officer

 

 

Forward-Looking Statement

This press release contains “forward-looking information” within the meaning of applicable securities legislation. All statements, other than statements of historical fact, included herein is forward-looking information. Generally, forward-looking information may be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “proposed”, “is expected”, “budgets”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. In particular, this press release contains forward-looking information in relation to; the impact of the changes to U.S. federal and state statutory developments with respect to the cannabis industry and the opportunities this may present for the Company; and the Company’s current liquidity. This forward-looking information reflects the Company’s current beliefs and is based on information currently available to the Company and on assumptions the Company believes are reasonable. These assumptions include but are not limited to the ability of the Company to successfully satisfy the conditions to closing the proposed transaction; the ability of the Company to successfully execute on its plans for the Company and GT; legal changes relating to the cannabis industry proceeding as anticipated.

 

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; the actual results of the Company’s future operations; competition; changes in legislation affecting the Company; the timing and availability of external financing on acceptable terms; lack of qualified, skilled labour or loss of key individuals; risks related to the COVID-19 pandemic including various recommendations, orders and measures of governmental authorities to try to limit the pandemic, including travel restrictions, border closures, non-essential business closures, service disruptions, quarantines, self-isolations, shelters-in-place and social distancing, disruptions to markets, economic activity, financing, supply chains and sales channels, and a deterioration of general economic conditions that could limit the Company’s ability to obtain external financing.

 

A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Company’s disclosure documents on the SEDAR website at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

 

Forward-looking information contained in this press release is expressly qualified by this cautionary statement. The forward-looking information contained in this press release represents the expectations of the Company as of the date of this press release and, accordingly, are subject to change after such date. However, the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether because of new information, future events or otherwise, except as expressly required by applicable securities law.

 

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accept responsibility for the adequacy or accuracy of this release.

 

AUSTRALIS CAPITAL INC.
Condensed Interim Consolidated Statements of Financial Position
(Unaudited – in Canadian Dollars)

 

Notes December 31,
2021
March 31,
2021
$ $
Assets
Current
Cash and cash equivalents 655,597 3,531,357
Accounts receivable 4 3,803,803 1,696,656
Inventory 659,395 473,185
Prepaid expenses 418,273 470,479
Current portion of deposits 1,303,734 649,464
Current portion of annuity receivable – SubTerra 59,576 66,070
Loans receivable 2,386,414
Marketable securities held for sale 5 2,890,022 12,803,638
Land held for sale 6 4,151,551
12,176,814 23,842,400
Non-current
Investment in ALPS technology solution APIS 8 3,034,309 1,130,233
Property, plant, and equipment 9 2,122,250 298,258
Right-of-use assets 9 754,156 1,097,361
Intangible assets 11 13,287,857 14,227,461
Goodwill 11 15,057,796 15,057,796
Derivative financial instrument – NCI call option 8 7,320,630 7,320,630
Annuity receivable – SubTerra 679,492 672,998
Long-term deposits 10 3,219,387 4,130,168
Other assets – acquisition deposit 7 14,797,896 14,677,674
TOTAL ASSETS 72,450,587 82,454,979
Liabilities
Current
Accounts payable and accrued liabilities 17 5,448,113 5,915,674
Deferred revenue 8,858 17,813
Current portion of lease liability 12 438,641 459,895
Provisions 10 1,029,014
5,895,612 7,422,396
Non-current
Contingent consideration payable 8 3,698,980 3,698,980
Lease liability 12 369,991 686,191
Loan payable 15 747,115
Deferred tax liability 3,205,244 3,205,244
TOTAL LIABILITIES 13,169,827 15,759,926
Shareholders’ equity
Share capital 13 112,002,679 104,617,900
Treasury shares 7,13 (11,367,770) (11,367,770)
Exchangeable shares reserve 13 10,383,426 11,114,175
Reserves 13 14,173,098 9,640,106
Accumulated other comprehensive income 323,717 234,035
Accumulated deficit (71,303,420) (52,937,270)
Equity attributable to owners of the Company 54,211,730 61,301,176
Non-controlling interest 8 5,069,030 5,393,877
TOTAL SHAREHOLDERS’ EQUITY 59,280,760 66,695,053
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 72,450,587 82,454,979

 

 

AUSTRALIS CAPITAL INC.
Condensed Interim Consolidated Statements of Financial Position
(Unaudited – in Canadian Dollars)

 

Three months ended
December 31,
Nine months ended
December 31,
Notes 2021 2020 2021 2020
Revenue $ $ $ $
Revenue-Services 1,993,131 8,430 5,137,007 43,102
Revenue-Kiosks 94,522 35,181 315,787 71,510
Revenue-Consulting 283,565 46,767 918,617 143,368
2,371,218 90,378 6,371,411 257,980
Cost of goods sold (527,781) (256,426) (2,229,669) (484,534)
Gross profit (loss) 1,843,437 (166,048) 4,141,742 (226,554)
Operating expenses
Wages and benefits 1,183,865 3,451,617 3,825,604 5,097,118
Share-based payments 13 1,097,784 (1,263,126) 3,759,580 391,507
Selling, general and administrative 14 3,476,327 2,557,961 7,415,624 4,137,737
Depreciation and amortization 9,11 406,543 152,341 1,281,555 496,355
6,164,519 4,898,793 16,282,363 10,122,717
Loss from operations (4,321,082) (5,064,841) (12,140,621) (10,349,271)
Other income (expense)
Gain on asset disposal (83,460) 82 (83,496) 138
Loss on investment in associate (427,739) (1,282,451)
Gain (loss) on sale of marketable securities (142,217) (180,880)
Loss on settlements (3,000,000) (237,338) (4,025,477)
Loss on true-up provision (1,615,835)
Loss on impairment – intertangle assets (7,684,824) (7,684,824)
Loss on remeasurement of land held for sale (2,250,241) (2,250,241)
Net change on investment at fair value through profit or loss 5 (275,278) (796,163) (6,202,654) (992,718)
Other income 70 483
Other expense – merger and acquisition costs (118,311) (286,846)
Foreign exchange gain (loss) 323,052 (88,989) 214,362 (87,192)
Income tax expense (77,596) (77,596)
Interest and other expense (184,599) (12,712) (94,436) (23,195)
Interest expense – leases (4,616) (4,880) (33,670) (38,685)
Interest income 62,259 26,460 145,332 86,120
(382,455) (14,357,247) (6,550,376) (18,200,723)
Net loss (4,703,537) (19,422,088) (18,690,997) (28,549,994)
Other comprehensive income (loss)
Foreign currency translation (175,046) 6,010 89,682 (247,153)
Share of OCI from investments in associates 144,441 (51,976)
Total comprehensive loss (4,878,583) (19,271,637) (18,601,315) (28,849,123)
Net loss attributable to:
Shareholders of the Company (4,714,729) (19,422,088) (18,366,150) (28,549,994)
Non-controlling interest 11,192 (324,847)
Net loss (4,703,537) (19,422,088) (18,690,997) (28,549,994)
Total comprehensive loss attributable to:
Shareholders of the Company (4,889,775) (19,271,637) (18,276,468) (28,849,123)
Non-controlling interest 11,192 (324,847)
Total comprehensive loss (4,878,583) (19,271,637) (18,601,315) (28,849,123)
Net loss per share attributable to shareholders of the Company
Basic and diluted (0.02) (0.11) (0.08) (0.17)
Weighted average number of shares outstanding
Basic and diluted 247,284,636 176,512,309 239,885,621 172,937,978

 

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading